This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Stallergenes. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Véronique Bordas
Introduction
Véronique Bordas is a notable inventor based in Antony, France. He has made significant contributions to the field of immunotherapy and diagnostics through his innovative work. His research focuses on developing natural-like allergens for therapeutic applications.
Latest Patents
Véronique Bordas holds a patent for "Recombinant Der P 2 expressed in Pichia Pastoris as a 'natural-like' allergen for immunotherapy and diagnostic purposes." This invention involves a method for producing a recombinant protein (rDer p 2) by cultivating a yeast strain transformed with a rDer p 2 coding sequence. The process includes isolating the rDer p 2 protein from the yeast strain. Additionally, the invention encompasses compositions and kits that utilize the rDer p 2 protein for therapeutic or diagnostic use. He has 1 patent to his name.
Career Highlights
Véronique Bordas is associated with Stallergenes, a company known for its focus on allergy immunotherapy. His work at Stallergenes has allowed him to contribute to advancements in the treatment of allergic conditions.
Collaborations
Some of his notable coworkers include Laetitia Bussieres and Sabi Airouche, who have collaborated with him on various projects within the field.
Conclusion
Véronique Bordas's innovative work in developing recombinant allergens has the potential to significantly impact immunotherapy and diagnostics. His contributions reflect the importance of research in addressing allergic conditions and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile